Versant Ventures V, LLC's Net Worth
$15.1 Million
Who is Versant Ventures V, LLC?
Versant Ventures V, LLC has an estimated net worth of $15.1 Million. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Repare Therapeutics Inc., Aprea Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., and CRISPR Therapeutics AG.
SEC CIK
Versant Ventures V, LLC's CIK is 0001619298
Past Insider Trading and Trends
2021 was Versant Ventures V, LLC's most active year for acquiring shares with 28 total transactions. Versant Ventures V, LLC's most active month to acquire stocks was the month of May. 2021 was Versant Ventures V, LLC's most active year for disposing of shares, totalling 42 transactions. Versant Ventures V, LLC's most active month to dispose stocks was the month of May. 2019 saw Versant Ventures V, LLC paying a total of $4,999,995.00 for 2,850,137 shares, this is the most they've acquired in one year. In 2022 Versant Ventures V, LLC cashed out on 1,601,202 shares for a total of $9,188,775.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turnstone Biologics Corp. (TSBX) Snapshot price: $2.2801
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.38M |
$12.00 |
—
| 3.38M |
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.54% | -1.45M |
$12.25 | -$9,188,775.00 | 4.98M |
Jun 3 - Jun 6
| |||
Form 4
| -39.68% | -152.07K |
—
|
—
| 231.21K |
Scheduled
|
Aug 5
| ||
Form 4
| -16.37% | -75.00K |
—
|
—
| 383.28K |
Jun 1
| |||
Form 4
| -9.99% | -240.75K |
—
|
—
| 2.17M |
Scheduled
|
May 5
| ||
Form 4
| -10.29% | -350.00K |
—
|
—
| 3.05M |
Scheduled
|
Feb 16
| ||
Form 4
| -9.36% | -600.00K |
—
|
—
| 5.81M |
Scheduled
|
Jan 29
| ||
Form 4
| -7.23% | -500.00K |
—
|
—
| 6.41M |
Scheduled
|
Jan 14
| ||
Form 4
| -10.12% | -325.00K |
—
|
—
| 2.88M |
Scheduled
|
Dec 15
| ||
Form 4
| +64.65% | 6.5M |
$20.00 | $5,000,000.00 | 16.54M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.00% | -507.59K |
—
|
—
| 2.88M |
Feb 4
| |||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.50% | -881.76K |
—
|
—
| 4.16M |
Apr 9 - May 18
| |||
Form 4
| +22,415.04% | 2.84M |
$15.00 | $4,999,995.00 | 2.85M |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $65.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.30% | -22.84K |
$50.90 | -$1,164,655.40 | 1.73M |
Scheduled
|
Apr 24
| ||
Form 4
| -33.33% | -2.30M |
—
|
—
| 4.61M |
Sep 5
| |||
| No matching records found | |||||||||